Noah L. Rosenberg
CIK 1579649 · CMO · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.56M
Companies
4
Total Filings
21
Lifetime Open-Market Net
-$356.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRCA | CMO | 2,357 | $5.73 | $13.5K | $10.0K | 3 | 2026-06-09 |
| TVTX | Chief Medical Officer | 49,021 | $52.04 | $2.55M | -$234.8K | 8 | 2021-08-17 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Chief Medical Officer | 27,555 | — | — | -$131.9K | 9 | 2020-09-23 |
| ESPR | Chief Medical Officer | — | $3.15 | — | $0 | 1 | 2013-07-25 |
Recent Filings · Page 2 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-01-25 | TVTX | Grant (A) | +15,000 | $0 | EDGAR |
| 2020-09-23 | Travere Therapeutics, Inc. (RTRX) Delisted | Sell (S) | −750 | -$13.9K | EDGAR |
| 2020-09-22 | Travere Therapeutics, Inc. (RTRX) Delisted | Mixed | +2,250 | -$13.9K | EDGAR |
| 2020-07-30 | Travere Therapeutics, Inc. (RTRX) Delisted | Sell (S) | −870 | -$17.8K | EDGAR |
| 2020-05-13 | Travere Therapeutics, Inc. (RTRX) Delisted | Sell (S) | −527 | -$9.0K | EDGAR |
| 2020-03-09 | Travere Therapeutics, Inc. (RTRX) Delisted | Mixed | +3,210 | -$27.5K | EDGAR |
| 2020-01-31 | Travere Therapeutics, Inc. (RTRX) Delisted | Grant (A) | +9,000 | $0 | EDGAR |
| 2019-07-31 | Travere Therapeutics, Inc. (RTRX) Delisted | Sell (S) | −2,500 | -$49.9K | EDGAR |
| 2019-05-10 | Travere Therapeutics, Inc. (RTRX) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
| 2018-07-30 | Travere Therapeutics, Inc. (RTRX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.